Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
Genzyme's Lemtrada resubmission accepted for review by FDA
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.
Extoxnet (extension toxicology network), 4-aminopyridine
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Significant Percentage of MS Patients Receiving Alemtuzumab in Genzyme’s Phase 2 Trial Remain Free of Clinically Active Disease
A complex role of herpes viruses in the disease process of multiple sclerosis.
Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.
Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling.
Molecular properties of epithelial, amiloride-blockable Na+ channels.
The Stigma Scale for Chronic Illnesses 8-Item Version (SSCI-8): Development, Validation and Use Across Neurological Conditions.
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
Glatiramer acetate does not protect from acute ischemic stroke in mice.
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Phase II Cladribine Add-on to Interferon-beta (IFN-b) Therapy in MS Subjecs With Active Disease (ONWARD)
Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.

Pages